DashboardPortafogliWatchlistCommunityScopriScreener
NOT FOR DISTRIBUTION

Evonik Industries AG

Report azionario XTRA:EVK

Capitalizzazione di mercato: €8.2b

  • Panoramica aziendale
    • Valutazione
    • Crescita futura
    • Performance passate
    • Salute finanziaria
    • Dividendo
  • Management
  • Proprietà
  • Altre informazioni
  • Comunità azionaria

Evonik Industries Gestione

Criteri Gestione verificati 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Claus Rettig

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del management1.4yrs
Durata media del Consiglio di amministrazione7.8yrs

Aggiornamenti recenti sulla gestione

Recent updates

User avatar
Aggiornamento narrativa • Sep 03

EVK: Execution On New Capacity Investments Is Expected To Support Re Rating

Analysts raised their fair value estimate for Evonik Industries to €22 from €21, citing recent price target increases from several banks and updated assumptions around revenue growth, profit margins and future P/E multiples. Analyst Commentary on Evonik Industries Recent research on Evonik Industries points to a more constructive tone, with several bullish analysts lifting their fair value assumptions and price targets.
User avatar
Aggiornamento narrativa • Aug 19

EVK: Fair Value View Weighs Q2 EBITDA Support Against Sector Headwinds

Analysts have modestly raised the fair value estimate for Evonik Industries from €17.78 to €18.28. The new estimate reflects a balance of higher Street price targets from banks, which are setting levels between €17 and €20, and more cautious views that point to structural and cyclical headwinds in the European chemicals sector.
Articolo di analisi • Aug 07

Here's What Analysts Are Forecasting For Evonik Industries AG (ETR:EVK) After Its Second-Quarter Results

It's been a good week for Evonik Industries AG ( ETR:EVK ) shareholders, because the company has just released its...
User avatar
Aggiornamento narrativa • Aug 05

EVK: Defensive Demand And Product Mix Are Expected To Support Re Rating

The updated fair value estimate for Evonik Industries moves to €21.0 from €20.4, with analysts pointing to recent price target increases across several banks and mixed rating changes that reflect differing views on earnings resilience, cost pressures and demand quality across the chemicals sector. Analyst Commentary Recent research on Evonik Industries shows a split view, although bullish analysts continue to highlight upside drivers that they see as underappreciated.
User avatar
Aggiornamento narrativa • Jul 17

EVK: Fair Value View Balances Defensive Demand With Mixed Rating Shifts

The updated analyst price target framework for Evonik Industries edges higher to about €17.78. This reflects a modest adjustment in fair value, a slightly lower discount rate, and broadly stable growth and margin assumptions as analysts balance recent target raises with more cautious sector calls.
User avatar
Aggiornamento narrativa • Jun 26

EVK: Restructuring And Polyester Exit Will Constrain Future Earnings Delivery

Analysts have raised the fair value estimate for Evonik Industries to €14.00 from €12.20. This change reflects updated assessments of revenue, margins and discount rates following a combination of higher price targets and rating changes in recent research reports.
Articolo di analisi • Jun 20

Evonik Industries (XTRA:EVK) Stock Could Be 6.7% Undervalued After Efficiency Plan

Evonik Industries (XTRA:EVK) has introduced a new efficiency plan that includes 3,200 job cuts by 2029 and an exit from its loss-making global polyester business, drawing fresh attention to the stock. See our latest analysis for Evonik Industries. The efficiency plan has arrived after a mixed period for Evonik Industries, with the 1-day share price return of 5.24% and 90-day share price return of 15.35% contrasting with a 1-year total shareholder return that is down 5.40%. This suggests...
User avatar
Aggiornamento narrativa • Jun 12

EVK: Methionine Pricing And Defensive Demand May Support Medium Term Re Rating

Analysts have raised the average price target for Evonik Industries to €20, up from the previous range of €17 to €19 in recent reports, reflecting updated views on earnings resilience, methionine pricing and defensiveness within European chemicals. Analyst Commentary The latest Street research on Evonik Industries presents a mixed picture, with both upgrades and downgrades across major brokers.
User avatar
Aggiornamento narrativa • May 29

EVK: Balanced Outlook As Rating Shifts And Defensive Demand Shape Future Performance

Analysts have lifted the fair value estimate for Evonik Industries from €16.16 to €17.23. This change reflects a mix of higher price targets across the Street, ongoing concerns about mid term earnings and returns, and support from factors such as elevated methionine spreads and what analysts describe as more defensive demand.
Articolo di analisi • May 15

There May Be Some Bright Spots In Evonik Industries' (ETR:EVK) Earnings

Evonik Industries AG's ( ETR:EVK ) recent soft profit numbers didn't appear to worry shareholders, as the stock price...
User avatar
Aggiornamento narrativa • May 03

EVK: Recent Upgrades And Dividend Support May Drive Medium Term Re Rating

Analysts have lifted their price targets on Evonik Industries by up to €2.40, reflecting updated views on slightly higher long term revenue growth and profit margins, alongside a modestly reduced discount rate and future P/E assumptions. Analyst Commentary Recent Street research on Evonik Industries has leaned clearly positive, with a cluster of upgrades and price target moves that underline improving confidence in the company’s long term fundamentals and valuation support.
User avatar
Aggiornamento narrativa • Apr 19

EVK: Recent Upgrades And Margin Outlook Will Support Medium-Term Re Rating Potential

Analysts have revised the fair value estimate for Evonik Industries from €19.90 to €20.40, reflecting updated views on revenue growth, profit margins and the P/E multiple following a series of recent upgrades and price target increases across the Street. Analyst Commentary Recent Street research shows a cluster of positive calls on Evonik Industries, with several bullish analysts adjusting their views and price targets in quick succession.
User avatar
Aggiornamento narrativa • Apr 03

EVK: Recent Rating Shifts And Earnings Execution Will Drive Future Share Performance

Analysts have lifted the fair value estimate for Evonik Industries from about €14.60 to roughly €16.16, reflecting updated assumptions on growth and profitability in the wake of several recent upgrades and price target increases across the Street. Analyst Commentary Recent research on Evonik Industries shows a mix of optimism and caution, with several upgrades and price target lifts set against earlier downgrades that focused on execution risks and earnings visibility.
User avatar
Aggiornamento narrativa • Mar 20

EVK: Margin Resilience And Lower Discount Rate Will Support Medium-Term Re Rating Potential

The analyst price target for Evonik Industries has been adjusted slightly higher to €19.90 from €19.77 as analysts factor in a modestly lower discount rate, slightly stronger margin assumptions, and a continued cautious view on revenue growth and future P/E. Analyst Commentary Recent Street research on Evonik Industries shows a mix of views, with some firms turning more cautious while others see improving risk reward.
User avatar
Aggiornamento narrativa • Mar 06

EVK: Weaker Pricing Power Will Limit Earnings Delivery Despite Mixed Broker Views

Analysts have raised their fair value estimate for Evonik Industries from €11.60 to €12.20, citing updated assumptions on revenue growth, the discount rate and future P/E that broadly reflect recent mixed Street research, including higher price targets and rating changes. Analyst Commentary Recent Street research on Evonik Industries has been mixed, with some firms turning more constructive and others flagging ongoing execution and earnings risks.
User avatar
Aggiornamento narrativa • Feb 20

EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
User avatar
Aggiornamento narrativa • Feb 06

EVK: Weaker Pricing Power Will Drive Lower Future Earnings Expectations

Analysts have trimmed their price expectations for Evonik Industries to around €11.60 per share, reflecting more cautious assumptions on revenue growth, profit margins and future P/E multiples following several recent downgrades and target cuts. Analyst Commentary Recent research points to a more cautious stance on Evonik Industries, with several bearish analysts trimming ratings and price targets and highlighting a mix of execution and earnings risks over the next few years.
Articolo di analisi • Feb 06

Evonik Industries AG (ETR:EVK) Not Flying Under The Radar

When close to half the companies in Germany have price-to-earnings ratios (or "P/E's") below 17x, you may consider...
User avatar
Aggiornamento narrativa • Jan 23

EVK: Sector Caution And Margin Execution Will Shape Future Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from €15.68 to €14.60, reflecting a softer view on revenue growth and profit margins, alongside recent sector downgrades and lower price targets from several banks. Analyst Commentary Recent Street research on Evonik Industries has tilted more cautious, with several firms cutting ratings or price targets and focusing on execution risks around pricing, volumes and sector positioning.
User avatar
Aggiornamento narrativa • Jan 08

EVK: Pricing And Volume Execution Risk Will Pressure Future Earnings

Analysts have cut their implied fair value for Evonik Industries from €17.50 to €11.60. This reflects a series of recent downgrades and lower price targets as they question the company’s ability to protect pricing and grow volumes in line with earlier expectations.
User avatar
Aggiornamento narrativa • Dec 23

EVK: Cost Discipline And Specialty Focus Will Support Medium-Term Upside Potential

Evonik Industries’ latest narrative update reflects a lowered analyst price target to EUR 20.40 from EUR 25.00, as analysts factor in softer revenue growth, slightly compressed profit margins, and a reduced future P/E multiple amid a more cautious sector stance. Analyst Commentary Recent Street research on Evonik Industries reflects a more nuanced view, with a mix of cautious sector positioning and selective optimism on the company’s ability to execute amid a tougher macro backdrop.
User avatar
Aggiornamento narrativa • Dec 09

EVK: Margin Resilience And Efficiency Measures Will Drive Future Upside Potential

The analyst price target for Evonik Industries has been revised modestly lower, from approximately EUR 16.14 to EUR 15.68. Analysts are factoring in softer revenue growth, slightly lower profit margins, and a more cautious sector stance, despite some institutions maintaining positive ratings.
Articolo di analisi • Dec 04

Evonik Industries (ETR:EVK) Has A Somewhat Strained Balance Sheet

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...
User avatar
Aggiornamento narrativa • Nov 24

EVK: Sector Challenges Will Be Overcome By Advancing Delivery Platform Collaboration

Evonik Industries’ analyst price target has been reduced from approximately €18.12 to €16.14. Analysts point to a more cautious outlook on the company’s prospects, citing a series of sector downgrades and lowered revenue growth expectations.
User avatar
Aggiornamento narrativa • Nov 06

EVK: Resilience And New Partnerships Will Drive Improved Revenue Outlook

Evonik Industries' analyst price target has been reduced slightly, with the updated consensus reflecting a minor decline of approximately EUR 0.25. Analysts cite ongoing cyclical and structural headwinds impacting earnings expectations.
Articolo di analisi • Oct 30

Evonik Industries AG's (ETR:EVK) Earnings Haven't Escaped The Attention Of Investors

With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...
User avatar
Aggiornamento narrativa • Oct 23

Analyst Views Mixed as Evonik Faces Softer Outlook Amid Valuation Adjustments and Strategic Moves

Evonik Industries' analyst price target has decreased modestly, dropping by approximately EUR 0.38 to EUR 18.37. Analysts cite increased caution due to reduced revenue growth expectations and ongoing earnings headwinds.
User avatar
Aggiornamento narrativa • Oct 09

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries’ analyst price target has been reduced from €19.88 to €18.75 as analysts cite increased downside risks to earnings from both cyclical and structural factors. Analyst Commentary Recent analyst activity reflects a mixed outlook on Evonik Industries, with both optimistic and cautious perspectives shaping the current consensus on the stock's valuation and prospects.
User avatar
Aggiornamento narrativa • Sep 25

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

Evonik Industries' consensus price target has been reduced from €20.49 to €19.88 as analysts factor in increased downside risks to earnings, moderating growth expectations, persistent margin concerns, and industry headwinds, prompting greater near-term caution. Analyst Commentary Bearish analysts highlight increased downside risks to earnings estimates due to both cyclical and structural pressures facing the company.
User avatar
Aggiornamento narrativa • Sep 04

Singapore And Slovakia Facilities And EU Incentives Will Shape Sustainability

With both the Future P/E and Discount Rate remaining essentially stable, analysts have maintained Evonik Industries' fair value unchanged at €20.49. Valuation Changes Summary of Valuation Changes for Evonik Industries The Consensus Analyst Price Target remained effectively unchanged, at €20.49.
User avatar
Nuova narrativa • Nov 25

Innovative Strategies And Cost Efficiency To Drive Exciting Growth In Emerging Sectors

Strategic realignment and cost-saving initiatives are expected to enhance focus on high-growth areas, reducing costs and improving net margins.

AMMINISTRATORE DELEGATO

Claus Rettig

no data
Mandato

Dr. Claus Rettig has been the Interim Chief Executive Officer and Deputy Chairman of the Management Board at Evonik Industries AG since Spetmeber 01, 2026. He serves as the Head of the Care Specialties Bus...


Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Thomas Wessel
Chief Human Resources Officer15yrs€2.36mNessun dato
Lauren Kjeldsen
COO of Custom Solutions & Member of the Management Board1.4yrs€1.34mNessun dato
Claudine Mollenkopf
COO of Advanced Technologies & Member of the Management Board1.4yrs€1.33mNessun dato
Claus Rettig
Interim CEO & Deputy Chairman of the Management Boardno dataNessun datoNessun dato
Michael Rauch
CFO & Member of Executive Boardless than a yearNessun datoNessun dato
Wilfried Ostendorf
Head of Production and Technologyno dataNessun datoNessun dato
Tim Lange
Head of Investor Relationsno dataNessun datoNessun dato
Thomas Mahlstedt
Vice President M&Ano dataNessun datoNessun dato
Christian Schmid
Head of Corporate Communications10.3yrsNessun datoNessun dato
Stefan Mack
Head of the Methionine & Derivatives Product Lineno dataNessun datoNessun dato
Matthias Ruch
Head of External Communications & Corporate Press Officerno dataNessun datoNessun dato
Gaetano Blanda
Head of Business Line Coating Additivesno dataNessun datoNessun dato
1.4yrs
Durata media
57.5yo
Età media

Gestione esperta: Il team dirigenziale di EVK non è considerato esperto (durata media 1.4 anni), il che suggerisce un nuovo team.


Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Bernd Tönjes
Independent Chairman of the Supervisory Board8.3yrs€395.00kNessun dato
Aldo Belloni
Independent Member of Supervisory Board9.3yrs€171.00kNessun dato
Werner Fuhrmann
Independent Member of Supervisory Board5.3yrs€171.00kNessun dato
Michael Rudiger
Independent Member of Supervisory Board13.5yrs€236.00kNessun dato
Alexandra Krieger
Employee Representative Member of Supervisory Board4.3yrs€168.00kNessun dato
Angela Titzrath
Independent Member of Supervisory Board10.3yrs€159.00kNessun dato
Barbara Albert
Independent Member of Supervisory Board12.2yrs€137.00kNessun dato
Cedrik Neike
Independent Member of Supervisory Board5.3yrs€157.00kNessun dato
Martin Kubessa
Employee Representative Member of the Supervisory Board8.3yrs€105.00kNessun dato
Martina Reisch
Employee Representative Member of Supervisory Board7.3yrs€122.00kNessun dato
Hussin El Moussaoui
Employee Representative Member of Supervisory Board6.8yrs€122.00kNessun dato
Alexander Bercht
Employee Representative Deputy Chairman of the Supervisory Board3yrs€277.00kNessun dato
7.8yrs
Durata media
59.5yo
Età media

Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di EVK sono considerati esperti (durata media dell'incarico 7.8 anni).


Analisi aziendale e situazione dei dati finanziari

DatiUltimo aggiornamento (ora UTC)
Analisi dell'azienda2026/09/16 04:33
Prezzo dell'azione a fine giornata2026/09/16 00:00
Utili2026/06/30
Utili annuali2025/12/31

Fonti dei dati

I dati utilizzati nella nostra analisi aziendale provengono da S&P Global Market Intelligence LLC. I seguenti dati sono utilizzati nel nostro modello di analisi per generare questo report. I dati sono normalizzati, il che può comportare un ritardo nella disponibilità della fonte.

PacchettoDatiTempisticaEsempio Fonte USA *
Dati finanziari della società10 anni
  • Conto economico
  • Rendiconto finanziario
  • Bilancio
  • Modulo SEC 10-K
  • Modulo SEC 10-Q
Stime di consenso degli analisti+3 anni
  • Previsioni finanziarie
  • Obiettivi di prezzo degli analisti
  • Rapporti di ricerca degli analisti
  • Blue Matrix
Prezzi di mercato30 anni
  • Prezzi delle azioni
  • Dividendi, scissioni e azioni
  • Dati di mercato ICE
  • Modulo SEC S-1
Proprietà10 anni
  • Top azionisti
  • Insider trading
  • Modulo 4 SEC
  • Modulo 13D SEC
Gestione10 anni
  • Team di leadership
  • Consiglio di amministrazione
  • Modulo SEC 10-K
  • Modulo SEC DEF 14A
Sviluppi principali10 anni
  • Annunci aziendali
  • Modulo 8-K SEC

* Esempio per i titoli statunitensi, per i titoli non statunitensi si utilizzano forme e fonti normative equivalenti.

Se non specificato, tutti i dati finanziari si basano su un periodo annuale ma vengono aggiornati trimestralmente. Si tratta dei cosiddetti dati TTM (Trailing Twelve Month) o LTM (Last Twelve Month). Per saperne di più.

Modello di analisi e Snowflake

I dettagli del modello di analisi utilizzato per generare questo report sono disponibili sulla nostra pagina GitHub; abbiamo anche delle guide su come utilizzare i nostri report e dei tutorial su YouTube.

Scoprite il che ha progettato e realizzato il modello di analisi Simply Wall St.

Metriche di settore e industriali

Le nostre metriche di settore e di sezione sono calcolate ogni 6 ore da Simply Wall St; i dettagli del nostro processo sono disponibili su Github.

Fonti analitiche

Evonik Industries AG è coperta da 30 analisti. 12 di questi analisti ha fornito le stime di fatturato o di utile utilizzate come input per il nostro report. Le stime degli analisti vengono aggiornate nel corso della giornata.

AnalistaIstituzione
Anil ShenoyBarclays
Andreas HeineBarclays
Sebastian BrayBerenberg

Prendi decisioni di investimento migliori ovunque

Scansiona per scaricare
Apri App StoreApri Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Visualizza le fonti dei dati
Mercati
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Idee di investimento
  • Società sottovalutate
  • Titoli a forte dividendo
  • Acquisto da parte di insider
  • Energia nucleare
  • Veicoli autonomi
  • Intelligenza artificiale
  • Cripto e blockchain
  • Cybersecurity
  • Altre idee
Comunità azionarie
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Funzionalità e strumenti
  • Tracker del portafoglio
  • Stock screener e avvisi
  • Narrazioni e valori equi
  • Calcolatore di dividendi
Notizie e scoperta
  • Ultime notizie sulle azioni
  • Approfondimenti sui mercati globali
  • La tana della volpe
  • Idee di investimento
  • Narrazioni della community
  • Novità
Simply Wall St
  • Piani e prezzi
  • Pubblicità
  • Chi siamo
  • Contattaci
  • Carriere
  • Centro assistenza
  • Impara a investire in azioni
  • Programma di affiliazione
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Termini e condizioni
  • Informativa sulla privacy
  • Termini sull'IA
  • Guida ai servizi finanziari